Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S C Rall

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Biochemistry|December 15, 1987
Comparison of cDNA-derived protein sequences of the human fibronectin and vitronectin receptor alpha-subunits and platelet glycoprotein IIbL A Fitzgerald, M Poncz, B Steiner, et al.
Journal of Lipid Research|March 1, 1994
Altered lipoprotein metabolism in transgenic mice expressing low levels of a human receptor-binding-defective apolipoprotein E variantS Fazio, Y Horie, W S Simonet, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 11, 1999
Overexpression of apolipoprotein E3 in transgenic rabbits causes combined hyperlipidemia by stimulating hepatic VLDL production and impairing VLDL lipolysisY Huang, Z S Ji, W J Brecht, et al.
European Journal of Biochemistry|October 15, 1984
Apolipoprotein A-IGiessen (Pro143----Arg). A mutant that is defective in activating lecithin:cholesterol acyltransferaseG Utermann, J Haas, A Steinmetz, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|November 1, 1994
Susceptibility to diet-induced atherosclerosis in transgenic mice expressing a dysfunctional human apolipoprotein E(Arg 112,Cys142)S Fazio, D A Sanan, Y L Lee, et al.
The Journal of Biological Chemistry|December 23, 1994
Co-expression of cholesteryl ester transfer protein and defective apolipoprotein E in transgenic mice alters plasma cholesterol distribution. Implications for the pathogenesis of type III hyperlipoproteinemiaS Fazio, K R Marotti, Y L Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1986
Platelet glycoproteins IIb and IIIa: evidence for a family of immunologically and structurally related glycoproteins in mammalian cellsI F Charo, L A Fitzgerald, B Steiner, et al.
The Journal of Biological Chemistry|May 25, 1989
Glycosylation of human apolipoprotein E. The carbohydrate attachment site is threonine 194M E Wernette-Hammond, S J Lauer, A Corsini, et al.
The Journal of Clinical Investigation|October 1, 1983
Identification of a new structural variant of human apolipoprotein E, E2(Lys146 leads to Gln), in a type III hyperlipoproteinemic subject with the E3/2 phenotypeS C Rall, K H Weisgraber, T L Innerarity, et al.
The Journal of Biological Chemistry|February 15, 1986
Human apolipoprotein E. Determination of the heparin binding sites of apolipoprotein E3K H Weisgraber, S C Rall, R W Mahley, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Biochemistry|December 15, 1987
Comparison of cDNA-derived protein sequences of the human fibronectin and vitronectin receptor alpha-subunits and platelet glycoprotein IIbL A Fitzgerald, M Poncz, B Steiner, et al.
Journal of Lipid Research|March 1, 1994
Altered lipoprotein metabolism in transgenic mice expressing low levels of a human receptor-binding-defective apolipoprotein E variantS Fazio, Y Horie, W S Simonet, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 11, 1999
Overexpression of apolipoprotein E3 in transgenic rabbits causes combined hyperlipidemia by stimulating hepatic VLDL production and impairing VLDL lipolysisY Huang, Z S Ji, W J Brecht, et al.
European Journal of Biochemistry|October 15, 1984
Apolipoprotein A-IGiessen (Pro143----Arg). A mutant that is defective in activating lecithin:cholesterol acyltransferaseG Utermann, J Haas, A Steinmetz, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|November 1, 1994
Susceptibility to diet-induced atherosclerosis in transgenic mice expressing a dysfunctional human apolipoprotein E(Arg 112,Cys142)S Fazio, D A Sanan, Y L Lee, et al.
The Journal of Biological Chemistry|December 23, 1994
Co-expression of cholesteryl ester transfer protein and defective apolipoprotein E in transgenic mice alters plasma cholesterol distribution. Implications for the pathogenesis of type III hyperlipoproteinemiaS Fazio, K R Marotti, Y L Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1986
Platelet glycoproteins IIb and IIIa: evidence for a family of immunologically and structurally related glycoproteins in mammalian cellsI F Charo, L A Fitzgerald, B Steiner, et al.
The Journal of Biological Chemistry|May 25, 1989
Glycosylation of human apolipoprotein E. The carbohydrate attachment site is threonine 194M E Wernette-Hammond, S J Lauer, A Corsini, et al.
The Journal of Clinical Investigation|October 1, 1983
Identification of a new structural variant of human apolipoprotein E, E2(Lys146 leads to Gln), in a type III hyperlipoproteinemic subject with the E3/2 phenotypeS C Rall, K H Weisgraber, T L Innerarity, et al.
The Journal of Biological Chemistry|February 15, 1986
Human apolipoprotein E. Determination of the heparin binding sites of apolipoprotein E3K H Weisgraber, S C Rall, R W Mahley, et al.
Pageof 7